Keros Therapeutics, Inc. (KROS)

Insiders sold $523K in the past 12 months, 18% under disclosed plans; their starting stakes can't be measured from the filings. Why

Latest filing: Filed Aug 20 for a sale on Aug 18. Esther Cho sold 4.5K shares ($46K) to cover taxes on vesting stock. Filing